Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

NCT00001596 is registered in ClinicalTrials.gov with William Gahl, M.D. as lead sponsor.

NCT NCT00001596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
Lead sponsor
William Gahl, M.D.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
May 9, 2016
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albinism, inborn errors of metabolism, oculocutaneous albinism, platelet storage pool deficiency, pulmonary fibrosis